The 7th Galien Forum Event:
The 2016 Galien Forum will take place on the morning of October 27th, 2016, and will feature round table debates focusing on critical global healthcare issues and challenges.

Our annual life science Forum is rapidly becoming a leading event for discussing issues of innovation in the industry. The Galien Forum brings together leading CEOs, biomedical experts from industry, academia and government.
Alexandria Center™ for Life Science -
450 East 29th Street, 2nd Floor
(between 1st Avenue and the East River)
New York City -7:30 AM- 5:00 PM

The 10th Galien Awards Ceremony
The Prix Galien Awards, is considered the industry’s equivalent of the Nobel Prize, the highest accolade for biomedical research and innovation.

Each year our distinguished Awards Committee, selects among many candidates the best products competing in three categories – Best Pharmaceutical Agent, Best Biotechnology Product and Best Medical Technology approved by the FDA in the past five years.
American Museum of Natural History
Central Park West at 79th Street
New York City - 6:30 PM

Book online your seat at the prestigious
Awards Ceremony and your day pass to
attend the Galien Forum.

Please contact us at (212) 685-1592 or
by mail
Join the Galien Foundation !
By joining the Galien Foundation, you will become a valued part of an elite community committed to scientific innovation and the improvement of human health.

Membership offers you the opportunity to attend unique networking events, and contribute to the voice of scientific research by sharing your ideas with leaders in the industry, academia and government.

Package A Individual Day Pass to the Galien Forum US $750.00

Package B Individual ticket to Awards Ceremony US $1,750.00

Package C Individual ticket to the Awards Ceremony and one Day Pass to the Galien Forum US $2,125.00

I would like to reserve 1 pass/seat

Preliminary Program

- 7:00 - 7:30: Welcome

- 07:45am - 08:50am: Bioengineering for Better Health: What Future for Targeted Drug Delivery?

Robert Langer, Chair, PhD, David H.Koch Institute Professor at MIT
Stephen Oesterle, MD, SVP Medicine & Technology, Medtronic, plc
Kevin J. Tracey, MD, President, Feinstein Institute, LIJ School of Medicine, Co-Founder, SetPoint Medical, Inc
Sean Caffey,MD, Co-Founder, Chairman, & CEO of Auricle, LLC. Co-Founder & Chairman of Replenish, Inc.
Cheryl R. Blanchard, Ph.D., CEO, Microchips Biotech, Inc.
William F. Doyle, Executive Chairman, NovoCure, Ltd.

- 08:50am - 09:55am: Autism - The Next Decade

Joel Marcus, Chair, Chairman, Chief Executive Officer & Founder, Alexandria Real Estate Equities, Alexandria Venture Investments; Co-Founder, Alexandria Summit
Geraldine Dawson, PhD, Professor, Department of Psychiatry and Behavioral Sciences & Director, Duke Center for Autism and Brain Development, Duke University School of Medicine
Stan Lapidus, President, Chief Executive Officer & Founder, SynapDx
Luca Santarelli, MD,Senior Vice President, Head of Neuroscience, Ophthalmology & Rare Diseases (NORD), Roche Pharma Research & Early Development, Roche
Laura Slatkin, Co-Founder, New York Collaborates for Autism
Lynne Zydowsky,Moderator, Ph.D. Chief Science Advisor to CEO, Alexandria Real Estate, Equities - Alexandria Venture Investments; President & Co-Founder, Alexandria Summit.

- 10:15am - 11:20am: Microbiota in Human Diseases*

Laurie Glimcher, Chair, MD, Dean of Weill Cornell Medical College and Provost for Medical Affairs, Cornell University, New York.
John Hambor, PhD, Distinguished Research Fellow, Research Administration Boehringer Ingelheim Pharmaceuticals, Inc.
Sarkis K Mazmanian, MD, Louis & Nelly Soux Professor of Microbiology, Division of Biology & Biological Engineering California Institute of Technology
David Artis, PhD, Michael Kors Professor of Immunology Director, Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill

- 11:20am - 12:00pm: Keynote

Dr. Jeff Gordon, Robert Glaser University. Professor and Director of the Center for Genome Sciences and Systems Biology at Washington University in St. Louis.

- 12:30pm - 1:45pm: US Health Reform: Partnering, Pricing and Politics

P. Roy Vagelos, Chair, M.D. Chairman of Regeneron Pharmaceuticals and retired Chairman and Chief Executive Officer of Merck & Co., Inc.
Peter B. Bach, MD, Director, Center for Health Policy & Outcomes, Memorial Sloan Kettering
Kenneth C. Frazier, Chairman, President & CEO, Merck & Co., Inc.
Robert Kocher, MD, Partner, Venrock
Jonathan Sheldon, Ph.D. Global Vice President, Oracle Health Sciences
Glenn D. Steele, Jr., MD, Chairman, xG Health Solutions /Former CEO, Geisinger Health System.

- 1:45pm - 2:50pm: Delivering on the Patient Promise of Gene Therapy*

Marc Tessier-Lavigne, Chair, MD, PhD., President, Professor Laboratory of Brain Development and Repair, The Rockefeller University, New York.
Margaret Hamburg, MD, former U.S. Commissioner of the FDA Nick Leschly, President and CEO of Bluebird

- 2:50pm - 3:55pm: Untangling the Web of Neurodegeneration: How Far and How Soon?*

Pr. Richard Axel, Chair, M.D., Nobel Laureate, Co-director, the Kavli Institute for Brain Science, Columbia University Medical Center, New York.

- 3:55pm - 5:15pm: Confronting the Crisis of Heart Failure: Innovation in Pharmacology and Medical Devices

Bengt Samuelsson, Chair, MD, PhD, Nobel Laureate, Former President of Karolinska institute and Former chairman of the Nobel Foundation. Stockolm, Sweden
Bud Frazier, MD, Professor of Surgery, Baylor College of Medicine and the University of Texas Health Science Center, Chief of the Center for Cardiac Support at The Texas Heart Institute.
John Mc Murray, MD, Professor of Medical Cardiology, Institute of Cardiovascular and Medical Sciences, University of Glasgow
Ameet Nathwani, MD, SVP & Global Head of Medical Affairs. Novartis
Lars Rydén, MD, Dr h.c., HMRCP, FESC, FACC, FAHA, Senior Professor of Cardiology at Karolinska Institutet, Stockholm, Sweden

Special dietary requirements

Enter your details